A New Chapter Begins

MycoWorks Acquired by DFx Corporation in Strategic Restructuring

MycoWorks announces its acquisition by DFx Corporation, a firm led by veteran restructuring specialist Daniel Frydenlund. The transaction marks a pivotal new chapter for the world’s leading Fine Mycelium™ platform — one defined by operational strength, renewed commercial momentum, and an unwavering commitment to bringing Reishi™ to the world at scale.

DFx Corporation brings more than three decades of experience identifying extraordinary assets and building the operational foundation they need to reach their full potential. Daniel Frydenlund has raised over $1 billion in capital and led the turnaround and exit of 17 technology companies across his career. In MycoWorks, he found something rare: a proprietary material platform with no peer in the world, and a product already proven to the most discerning buyers in luxury fashion.

Under DFX stewardship, MycoWorks will deepen its partnerships with the brands and craftspeople who believe in the future of Fine Mycelium™, invest in the technology and production capabilities that have always set Reishi™ apart, and build the long-term operational stability the platform deserves.

Fine Mycelium was never just a material. It was proof that nature’s own processes can produce something more beautiful, more considered, and more enduring than anything petrochemicals can offer. That proof stands. And now, with new ownership committed to the long game, MycoWorks is ready to grow again.

Our journey together is just beginning — again.